【レポートの概要（一部）】
1. Executive Summary
1.1 What Does This Report Cover?
1.1.1 The Human Tissue Banking Market – Our Definition
1.1.2 The Stem Cell Banking Market – Our Breakdown
1.2 Biobanking for Medicine: Technology, Industry and Market 2014-2024 Overview
1.3 Chapter Outlines
1.4 Speculative Aspects of Assessing the Biobanking Market
1.5 Research and Analysis Methods
1.6 Glossary of Terms in this Report
2. Introduction to Biobanking and its Applications
2.1 What is Biobanking?
2.2 Main Features of Biobanks
2.3 What Processes are Involved in Biobanking?
2.4 Classification of Biobanks: Tissue Type, Volunteer Group and Ownership Classification Models
2.4.1 Volunteer Group: Population- vs. Disease-Based
2.4.2 Ownership Structure: Public vs. Private
2.5 The Guidelines and Standards for Biobanking
2.6 Laws and Regulations for Biobank-Based Research
2.6.1 HIPAA Amendments
2.7 Biobanking and the Pharmaceutical Industry
2.7.1 Biobanking in Research, Drug Discovery and Development
2.7.1.1 Understanding Disease Pathways
2.7.1.2 Drug Discovery
2.7.1.3 Biomarker Discovery in Drug Development
2.7.2 Biobanking for Therapeutics
2.7.3 Biobanking in Clinical Trials
3. Biobanking for Medicine: World Market 2014-2024
3.1 The World Biobanking for Medicine Market in 2013
3.2 Biobanking for Medicine: Research vs. Therapeutics in 2018 and 2024
3.3 World Biobanking for Medicine Market: Overarching Revenue Forecast 2014-2024
3.4 Biobanks Stored Almost 1.3 Billion Specimens in 2013, and That Figure Increases
3.5 The Biobanking for Medicine Market by Sector: Grouped Revenue Forecasts 2014-2024
3.6 Biobanking for Research: A $10bn Industry
3.6.1 Biobanking for Research: Revenue Forecast 2014-2024
3.6.2 Driving Forces Outweigh Restraints on the Biobanking Industry for Research
3.7 Biobanking for Future Therapeutic Use: A Worthwhile Endeavour or a Waste of Money?
3.7.1 Arguments Against Commercial Stem Cell Banking for Therapeutic Purposes
3.7.2 Biobanking for Future Therapeutic Use: Revenue Forecast 2014-2024
3.7.3 Driving and Restraining Forces Influencing the Biobanking Market for Therapeutic Use, 2014-2024
4. Biobanking for Research Purposes
4.1 Breakdown of the Biobanking for Research Market by Tissue Type, 2013
4.2 Biobanking for Research in 2018 and 2024: Comparison by Tissue Type
4.3 Biobanking for Research by Tissue Type: Grouped Revenue Forecasts 2014-2024
4.4 How Many Specimens are Biobanked for Research?
4.5 The Human Tissue Banking Market for Research in 2013
4.6 The Human Tissue Banking Market for Research: Revenue Forecast 2014-2024
4.7 The Human Tissue Banking Market: Commercial vs. Public Sector
4.7.1 Commercial Human Tissue Banks: Revenue Forecast 2014-2024
4.7.2 Public Sector Human Tissue Banks: Revenue Forecast 2014-2024
4.8 The Stem Cell Banking Market for Research in 2013
4.9 The Stem Cell Banking Market for Research: Revenue Forecast 2014-2024
4.9.1 A Shift in R&D Towards Stem Cells
4.10 Banking of Other Biologic Specimens for Research in 2013
4.11 Banking of Other Biologic Specimens for Research: Revenue Forecast 2014-2024
5. Stem Cell Banking for Future Therapeutic Use
5.1 Stem Cell Banking for Therapeutic Use in 2013: A Breakdown by Stem Cell Type
5.2 Stem Cell Banking for Therapeutic Use by Stem Cell Type: Comparison of Revenue and Market Share, 2018 and 2024
5.3 Stem Cell Banking for Therapeutic Use by Stem Cell Type: A Grouped Revenue Forecast
5.4 How Many Stem Cell Samples Are Biobanked Each Year?
5.5 The Umbilical Cord Blood Banking Market in 2013
5.5.1 Private vs. Public Cord Blood Banking
5.5.2 Umbilical Cord Blood Banking: The Controversies
5.6 The Umbilical Cord Blood Banking Market: Revenue Forecast 2014-2024
5.7 The Adult Stem Cell Banking Market in 2013
5.8 The Adult Stem Cell Banking Market: Revenue Forecast 2014-2024
6. Leading National Markets 2014-2024
6.1 The Geographical Footprint of Biobanking
6.1.1 Biobanking in Europe: Leading the World with Biobanking Networks and Infrastructure
6.1.2 Biobanks in the US: A Fragmented Picture
6.1.3 Biobanking in Asia: A Region Rapidly Gaining Prominence
6.2 Biobanking for Medicine: The US Led the Way in 2013
6.3 The Leading National Markets: A Grouped Revenue Forecast 2014-2024
6.4 How Will Regional Market Shares Change to 2024?
6.5 The US Biobanking Market 2014-2024: Diversifying and Expanding
6.6 The Leading European Biobanking Markets 2014-2024: Leading the Way in Biobanking Infrastructure
6.6.1 Germany: An Advanced Industry with 74 Biobanks Associated with the BBMRI
6.6.2 France: Restrictions on Private Stem Cell Banking Limit the Market
6.6.3 Italy: Is the Limited Private Stem Cell Banking Market Off-Set by Strong Biobanking Networks for Research?
6.6.4 UK: 215 Biobanks Were Licensed Under the HTA in 2013
6.6.5 Spain: Controversy Between Private and Public Umbilical Cord Blood Banks
6.6.6 The Netherlands is Characterised by Comprehensive Biobanking Networks
6.7 The Japanese Biobanking Market 2014-2024: A High Level of Government Investment Drives Growth
6.8 The Biobanking Industry in the BRIC Countries: High Growth and Increasing Market Share Between 2014 and 2024
6.8.1 The Chinese Biobanking Market 2014-2024: The High Rate of Growth Will Continue
6.8.2 The Indian Biobanking Market 2014-2024: Set to Become the Leading Market for Private Stem Cell Banking?
6.8.3 The Brazilian Biobanking Market 2014-2024: Will New Regulations Drive or Restrain the Market?
6.8.4 Russia: Ban on the Import and Export of Human Tissue and Genetic Information Restricts the Market, But Can This Be Overcome from 2014-2024?
7. Technology for Biobanking: Systems, Software, Consumables and Services Associated with Biobanking
7.1 The Biobanking-Associated Market: Overview
7.2 Systems Technology: Fully Automated Handling
7.2.1 Automated Liquid Handling Systems
7.2.2 Frozen Aliquotting: Patented Technology From CryoXtract
7.2.3 Automated DNA Isolation
7.3 Storage Technology: The Most Important Component of Biobanking?
7.3.1 Dry State, Room Temperature Storage Eliminates the Need for Expensive, Energy- Consuming Freezers
7.3.2 Ultra-Low Temperature Freezers: Is Their Use Declining?
7.3.3 Cryopreservation: Mechanical vs. Liquid/ Vapour Phase Nitrogen
7.3.4 Automated Storage and Retrieval Systems: Essential Technology
7.3.5 RFID and Tagging Technology: Advantages over Barcodes
7.4 Software for Biobanks
7.4.1 Laboratory Information Management System (LIMS): Unmet Needs in the Market Remain, Despite Recent Advances
7.4.2 LIMS Functions
7.5 Consumables: High Quality Required for Effective Sample Management
7.5.1 Addressing Sample Storage and Tracking Issues
7.6 Biobanking Services: Storage, Management and Transport of Biologic Samples for a Fee
8. Leading Companies in the Biobanking Market
8.1 The Differing Business Models of Biobanking Companies: Sourcing vs. Storing
8.2 Commercial Biobanks for Research Purposes in 2013
8.2.1 Tissue Solutions: A Virtual Biobank with a Global Presence
8.2.1.1 An Overview of the Products and Services Offered by Tissue Solutions
8.2.1.2 Banked Samples Occur in Many Formats
8.2.1.3 Prospective Tissue Collection for Hard-to-Find Samples
8.2.1.4 Fresh Samples from Surgical Resections are in High Demand
8.2.1.5 Freshly Isolated Human Cells are a Valuable Research Tool
8.2.1.6 FDA/ EMA Panel of Normal Tissues
8.2.1.7 Strengths, Capabilities and the Future Outlook for Tissue Solutions
8.2.2 Asterand is now Part of Stemgent
8.2.2.1 Asterand’s Products and Services: XpressBANK, ProCURE and PhaseZERO
8.2.3 Biopta Provides Fresh Human Tissues, for Which Demand is Growing
8.2.3.1 Services From Biopta: Fresh Tissue Sample Procurement and a Variety of Lab Services
8.2.3.2 The First Catalogue of Assays Based on Human Functional Tissues
8.2.3.3 The Future Outlook for Biopta
8.2.4 BioServe: One of the World’s Largest Commercial Biorepositories
8.2.4.1 BioServe Offers a Comprehensive List of Services: Biobanking, Sourcing and Preclinical Molecular Services
8.2.4.2 The Future Outlook for BioServe
8.2.5 Coriell Institute for Medical Research: Reportedly the Largest Biobank in the World
8.2.5.1 Features of Coriell Biobank
8.2.5.2 Future Outlook for the Coriell Biobank
8.3 Prominent Biobanks for Therapeutic Use in 2014
8.3.1 Cord Blood America: Expansion into the Emerging Markets Apparently Stalled
8.3.2 Cryo-Cell International: The First Private Cord Blood Bank in the Market
8.3.3 Cryo-Save’s Educational Programme Benefits Company’s Growth
8.3.4 China Cord Blood Corp: The Only Cord Blood Bank in China with Multiple Licences
8.3.5 LifebankUSA: Placental and Cord Blood Banking Means a Significant Survival Advantage in Transplant Patients
8.3.6 ViaCord: More Blood Units Released for Therapy than Any Other Family Bank
8.3.7 Cord Blood Registry: The World’s Largest Newborn Stem Cell Company, Accounting for 3% of the Private Stem Cell Banking Industry
8.3.8 Biogenea Pharmaceuticals: A Comprehensive Offering of Stem Cell Banking Services across the Balkan Peninsula
8.3.9 StemLife is Facing Challenges due to Government Regulations in Malaysia
8.3.10 Future Health Biobank: A Strong Market Presence Owing to International Operations
8.3.11 NeoStem Operates a Multi-Faceted Business Strategy
8.3.12 Precious Cells is Well Positioned to Take Advantage of the Growing Demand in India
9. Qualitative Analysis of the Biobanking Industry and Market 2014-2024
9.1 Industry Trends
9.1.1 The Growing Demand for Biobank Resources for Research
9.1.2 The Establishment of Biobanking Networks
9.1.2.1 BBMRI: The Most Extensive Biobank Network
9.1.3 Virtual Biobanks: Connecting a Fragmented Industry
9.1.4 Commercial Biobanks as Intermediaries: New Resources for Research
9.1.5 Automated Biobanking Has Become Imperative
9.1.6 Increasing Uptake of LIMS
9.1.7 Green Banking – Becoming More Energy Efficient
9.2 The Strengths and Weaknesses of the Biobanking Market in 2014
9.2.1 HBS are Valuable Resources for R&D
9.2.2 Governmental Support for Biobanking Forms a Strength of that Industry
9.2.3 Development of Potential Novel Stem Cell Therapies has Increased Public Awareness of Stem Cell Banking
9.2.4 Insufficient Accessible Numbers of High Quality Biospecimens
9.2.5 Biobanks are Fragmented and Uncoordinated
9.2.6 Lack of Standardisation is a Weakness of the Industry
9.2.7 Lack of Public Awareness Limits Number of Donors
9.2.8 Lack of Engagement with Public Health Services Limits the Stem Cell Banking Market
9.3 Opportunities and Threats Facing the Biobanking Market, 2014-2024
9.3.1 Increasing Use of Biobanked Specimens in Genome-Wide Association Studies (GWAS)
9.3.2 Increasing Demand for Biobanked Samples for Preclinical Research
9.3.3 Biobanking Networks as a Basis for Personalised Medicine
9.3.4 Options for Adult Stem Cell Banking Mean an Increasing Target Population for Private Stem Cell Banks
9.3.5 Even With Governmental Funding, Biobanks Must Become Self-Sufficient to Thrive Long Term
9.3.6 Public Concerns over Confidentiality and Security Threaten Availability of Donors
9.3.7 Limitations Surrounding Informed Consent
9.4 Social, Technological, Economic and Political Factors (STEP) Influencing the Biobanking Industry, 2014-2024
10. Research Interviews from Our Survey
10.1 Interview with Dr Kirstin Goldring, Biobank and BioResource Coordinator, University College London, UK
10.1.1 On the Size of the UCL Biobank and How its Growing
10.1.2 On Users of UCL Biobank
10.1.3 On the Increasing Demand for Biobanked Samples
10.1.4 On Technology Used at UCL Biobank
10.1.5 On the Cost of Access to Samples
10.1.6 Concerns, Challenges and Restraining Factors
10.1.7 The Future of Biobanking
10.2 Interview With Dr Husein Salem, Chief Executive Officer, Precious Cells BioBank, London
10.2.1 On the Increasing Demand for Stem Cell Banking Services
10.2.2 On Novel Stem Cell Therapies in Development
10.2.3 Storage of Adult Stem Cells vs. Storage of Umbilical Cord Blood
10.2.4 On the Demand for Stem Cell Banking in Different Countries
10.2.5 On Challenges in the Industry
10.2.6 On Technology Used at Precious Cells
10.2.7 On Unmet Needs in the Stem Cell Banking Industry
10.2.8 On the Future of Stem Cell Banking
10.3 Interview with Dr David Bunton, CEO and Co-Founder, Biopta Ltd.
10.3.1 One the Use of Human Tissue Samples by Biopharmaceutical Companies
10.3.2 Human Tissue vs. Stem Cells
10.3.3 On the Technology Used in Biobanks
10.3.4 On the Future of the Biobanking Market
10.4 Interview with Dr Michael Leek, Commercial Operations Director, Pharmacells
10.4.1 On the Recent Increase in Stem Cell Banking Activity
10.4.2 On the Services of Pharmacells
10.4.3 On Adult Stem Cell Banking vs. Umbilical Cord Blood Banking
10.4.4 On Challenges Facing the Stem Cell Banking Market
10.4.5 On the Technology Used by Pharmacells
10.4.6 On the Future of the Market
10.5 Interview with Dr Tetsuro Wakatsuki, Chief Scientific Officer, InvivoSciences Inc.
10.5.1 On the Services Provided by InvivoSciences
10.5.2 On the Future of this Biobanking-Associated Market
11. Conclusions from the Research and Analysis
11.1 World Biobanking Market 2014-2024: High Revenue Growth Predicted
11.2 Biobanking for Research 2014-2024: The Value of Biobanked Specimens is Increasingly Recognised
11.3 Biobanking for Therapeutic Use 2014-2024: Rapid Expansion in Adult Stem Cell Banking
11.4 The Leading National Markets: High Sales Growth Worldwide
11.5 Current and Future Trends in Biobanking
11.5.1 Increasing Demand for Biobanked Samples Means Increasing Revenue
11.5.2 Improving Biobanking Infrastructure Engenders Growth
11.5.3 Marked Challenges, but Opportunities for Expansion
【レポート販売概要】
■ タイトル：医療用バイオバンキング市場（2014-2024）■ 英文：Biobanking for Medicine: Technology, Industry and Market 2014-2024
■ 発行日：2014年3月
■ 調査会社：visiongain
■ 商品コード：Visiongain-4052639
■ 調査対象地域：グローバル
- 3Dカメラの世界市場2015-2019About 3D camera A 3D camera is used to capture or record images or visuals in 3D format; this camera helps enhance the quality of images and visuals. An image captured by 3D camera is of good quality compared to that through a 2D camera. Also, it is possible to view the in-depth detail to the image compared an image captured by a 2D camera. For instance, Intel has recently introduced realsense 3D …
- 顕微鏡の世界市場：光学顕微鏡、電子顕微鏡、共焦点顕微鏡、走査プローブ顕微鏡Rising Focus on Nanotechnology, Technological Advancements, and Increasing Federal Support to Drive Growth of the Microscopy Market Developing markets such as the Middle East, Brazil, Argentina, Mexico, China, and India are lucrative markets for microscopy, owing to favorable government incentives and corporate funding. The report segments the global microscopy market by product, application, end …
- 自動車用複合材料の世界市場：高分子基複合材料、金属基複合材料、セラミックス基複合材料Composites have found wide acceptance in various industries including automotive because of their light weight and environmental resistance characteristics. On the basis of application areas, the market of automotive composite can be broadly segmented into interior, exterior, chassis & powertrain components and others. Though exterior components is the major application of automotive composite, ch …
- 難燃剤の世界市場：三水和アルミナ（ATH）、酸化アンチモン、臭素系、塩素系、リン系Flame retardants are key components used in reducing the devastating effect of fire mishaps on people, property, and the environment. Most common elements used as flame retardants are bromine, chlorine, and phosphorous. The compounds of these elements are added to or treat potentially flammable materials. Flame retardants stop the fire by interacting with the fire cycle in the gaseous phase and st …
- パワードスマートカードの世界市場：タイプ別（接触型スマートカード、非接触型スマートカード、ハイブリッド・デュアルインターフェイススマートカード）、コンポーネント別（マイクロプロセッサ、メモリスマートカード）、用途別（テレコム、政府機関・ヘルスケア、金融サービス、小売・ロイヤルティ、有料テレビ、運輸）、地域別予測Global Powered Smart Card Market to reach USD 5749.8 million by 2025. Global Powered Smart Card Market valued approximately USD 2062.2 million in 2016 is anticipated to grow with a healthy growth rate of more than 60.4% over the forecast period 2017-2025. The driving factor for powered smart card market is the Growing demand for secure and reliable payment transactions, improved security for offic …
- TurkeyのBinoculars市場：貿易（輸入、輸出）動向This market research report examines the foreign trade of Turkey and its perspectives on the global market for binoculars. The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on binoculars export/import operations in Turkey. The 2002-2012 period is covered, with more emphasi …
- 胆管癌(肝内胆管癌)(Bile Duct Cancer (Cholangiocarcinoma))：世界の治験レビュー（2015年上半期版）Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2015" provides data on the Bile Duct Cancer (Cholangiocarcinoma) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bile Duct Cancer (Cholangio …
- ゲームベースドラーニング（シリアスゲーム）の世界市場About Game-based Learning Game-based learning or serious game refers to all digital applications that are developed to impart learning through games. This encourages learning in players by taking advantage of the psychological susceptibility of humans to engage in gaming. Game-based learning includes digital learning products such as e-learning courseware, online audio and video content, social ga …
- 医療レポート：Acute Myeloid Leukemia-疫学予測（～2022）EpiCast Report: Acute Myeloid Leukemia - Epidemiology Forecast To 2022 Summary Acute myeloid leukemia (AML) is a rare cancer that accounts for a disproportionally high number of cancer-related deaths (O’Donnell et al., 2012; RKI, 2012). The disease is more common in the elderly and is slightly more common in men than in women (ACS, 2013; O’Donnell et al., 2012). AML progresses quickly and has low …
- 世界のSIサービス（System Integration Service）市場動向（2012-2016）TechNavio's analysts forecast the Global System Integration Services market to grow at a CAGR of 5.86 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for cloud-based system integration services. The Global System Integration Services market has also been witnessing the demand for specialist system integrators. However, the unsta …
- 工業塩の世界市場2016-2020About Salt Salt finds substantial application in the chemical manufacturing and water treatment industries. It is produced globally through production processes such as solar evaporation, brine extraction mining, and rock salt mining. Sea water is an unlimited source of salt, but salt production along the coastline is restricted by soil and weather conditions. Technavio’s analysts forecast the glo …
- モバイルビジネスインテリジェンス（BI）の世界市場予測（～2021）：種類別（ソフトウェア、サービス）、ビジネス機能別、ビジネス用途別、企業規模別、産業別、地域別The mobile Business Intelligence (BI) market size is expected to grow from USD 4.08 Billion in 2016 to USD 11.13 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 22.2% during the forecast period. The major growth drivers of the mobile BI market include increase in the Bring Your Own Device (BYOD) trend, rise of Mobile Enterprise Application Platform (MEAP), growing popularity of Represe …
- 業務用冷凍装置の世界市場：ディープフリーザー、ボトルクーラー、ストレージウォータークーラー、業務用キッチン冷凍、医療冷凍、チェスト冷凍Commercial refrigeration equipment are used for preserving food such as vegetables, fruits, meat, and other similar products, by maintaining a temperature of 30C to -40C and increasing the shelf life of the product. Relatively larger share of the market for refrigerators is expected to be accounted for in the near future due to replacement of existing equipment through energy efficient and sustain …
- 消費者向けIoTの世界市場予測（～2023年）“Consumer preference for increased convenience and better lifestyle drives overall consumer IoT market”The consumer IoT market is estimated to be USD 46.8 billion by 2018 and is projected to reach USD 104.4 billion by 2023, at a CAGR of 17.39%. The growth of the consumer IoT market can be attributed to the growing number of internet users and adoption of smart devices, increasing awareness about f …
- 光ファイバーセンサの世界市場予測及び分析This is the ElectroniCast forecast of global market consumption of Fiber Optic Sensors. The quantitative market forecast data presented in this study report, covering the years 2014-2019, are segmented into the following geographic regions, plus a Global summary: • The Americas (North America, Central and South America) • EMEA (Europe, Middle Eastern countries, plus Africa) • APAC (Asia Pacific) N …
